She was 13 and out of options until an experimental treatment worked #shorts

Medical Breakthrough - A 13-year-old patient with a rare form of leukemia, Alyssa Tapley, was facing end-of-life care after failed treatments [1][2] - The patient received an experimental gene editing treatment funded by US federal funding after other treatments failed [2][3] - The patient became the first human to try the experimental treatment [3] - The experimental treatment was successful, leading to the patient's cancer remission [4] Research & Development Impact - The successful treatment highlights the potential of gene editing research in treating rare and difficult diseases [2][4] - The case demonstrates the significant impact of research and resource allocation in medical advancements [4]